Hypertension and kidney transplantation

Area of Science:

• Nephrology
• Transplant Surgery
• Cardiology

Background:

• Post-transplant hypertension is a frequent complication affecting kidney transplant recipients.
• It significantly impacts long-term patient and allograft survival rates.
• Hypertension is multifactorial, with some causes amenable to intervention.

Purpose of the Study:

• To highlight correctable causes of hypertension in kidney transplant patients.
• To discuss the role of immunosuppressive agents in post-transplant hypertension.
• To outline current and future therapeutic strategies for managing this complication.

Main Methods:

• Review of existing literature on post-transplant hypertension.
• Analysis of contributing factors including surgical, radiologic, and pharmacologic elements.
• Discussion of therapeutic interventions, both corrective and medical.

Main Results:

• Stenosis and native kidney-associated hypertension are identifiable and correctable causes.
• Common immunosuppressive drugs like prednisone and cyclosporine can exacerbate hypertension.
• Medical therapy, including vasodilating drugs and diuretics, is often effective.

Conclusions:

• Physicians must consider correctable etiologies of hypertension in kidney transplant recipients.
• Immunosuppressive regimens require careful consideration due to their hypertensive effects.
• A combination of addressing correctable causes and appropriate medical management is key to improving outcomes.